Does Rallies show 13F holders for TVGN?

Yes. Rallies tracks hedge fund and 13F ownership data for TVGN, including fund names, share counts, latest tracked quarter, and position changes when available.

Is TVGN research on Rallies investment advice?

No. Rallies provides research, data, and educational context for TVGN. It does not provide personalized investment advice.

TVGN (Tevogen Bio Holdings Inc. Common Stock) Stock Analysis - Hedge Fund Holdings

Tevogen Bio Holdings Inc. Common Stock (TVGN) is a publicly traded Healthcare sector company. As of May 21, 2026, TVGN trades at $10.48 with a market cap of $37.19M and a P/E ratio of -1.24. TVGN moved +0.00% today. Year to date, TVGN is -41.62%; over the trailing twelve months it is -81.93%. Its 52-week range spans $4.14 to $154.50. Analyst consensus is neutral with an average price target of $0.00. Rallies surfaces TVGN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns TVGN stock?

Hedge funds tracked by Rallies that own TVGN include Citadel Advisors and Two Sigma. The latest tracked quarter is Jun 30, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Tevogen Bio Holdings Inc. Common Stock.

TVGN Key Metrics

Key financial metrics for TVGN
Metric	Value
Price	$10.48
Market Cap	$37.19M
P/E Ratio	-1.24
EPS	$-8.08
Dividend Yield	0.00%
52-Week High	$154.50
52-Week Low	$4.14
Volume	0
Avg Volume	0
Revenue (TTM)	$-195.62K
Net Income	$-26.28M
Gross Margin	0.00%

Top Hedge Funds Holding TVGN

Citadel Advisors holds 48.40K shares of TVGN, changed +0.00% as of Jun 30, 2024.
Two Sigma holds 11.41K shares of TVGN, changed +0.00% as of Jun 30, 2024.

Latest TVGN News

Tevogen Secures $3M PIPE at $8 Per Warrant, 14% Premium — May 12, 2026
Tevogen Initiates Commercial Readiness for PredicTcell AI Model After 10% Precision Gain — Apr 27, 2026
Tevogen Eyes CRO Acquisition Across 20 Countries to Add $20M Revenue — Mar 26, 2026
Tevogen Regains $1.00 Nasdaq Bid Price Compliance, Pursues Acquisitions — Mar 25, 2026
Tevogen.AI Boosts PredicTcell Accuracy to 92% Recall and 48% Precision — Mar 13, 2026

Recent TVGN Insider Trades

Flomenberg Neal sold 501 (~$3.21K) on Mar 13, 2026.
Flomenberg Neal sold 452 (~$3.28K) on Mar 11, 2026.
Flomenberg Neal sold 19 (~$147.25) on Mar 10, 2026.

TVGN Analyst Consensus

1 analysts cover TVGN: 0 strong buy, 0 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $0.00.

Common questions about TVGN

Who owns TVGN stock?: Hedge funds tracked by Rallies that own TVGN include Citadel Advisors and Two Sigma. The latest tracked quarter is Jun 30, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Tevogen Bio Holdings Inc. Common Stock.
Does Rallies show 13F holders for TVGN?: Yes. Rallies tracks hedge fund and 13F ownership data for TVGN, including fund names, share counts, latest tracked quarter, and position changes when available.
Is TVGN research on Rallies investment advice?: No. Rallies provides research, data, and educational context for TVGN. It does not provide personalized investment advice.